Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Ann Epidemiol ; 37: 51-56.e6, 2019 09.
Article in English | MEDLINE | ID: mdl-31451313

ABSTRACT

PURPOSE: Manifestations of infection and the degree of influenza virus vary. We hypothesized that the nose/throat microbiota modifies the duration of influenza symptoms and viral shedding. Exploring these relationships may help identify additional methods for reducing influenza severity and transmission. METHODS: Using a household transmission study in Nicaragua, we identified secondary cases of influenza virus infection, defined as contacts with detectable virus or a greater than 4-fold change in hemagglutinin inhibition antibody titer. We characterized the nose/throat microbiota of secondary cases before infection and explored whether the duration of symptoms and shedding differed by bacterial community characteristics. RESULTS: Among 124 secondary cases of influenza, higher bacterial community diversity before infection was associated with longer shedding duration (Shannon acceleration factor [AF]: 1.61, 95% confidence interval [CI]: 1.24, 2.10) and earlier time to infection (Shannon AF: 0.72, 95% CI: 0.53, 0.97; Chao1 AF: 0.992, 95% CI: 0.986, 0.998). Neisseria and multiple other oligotypes were significantly associated with symptom and shedding durations and time to infection. CONCLUSIONS: The nose/throat microbiota before influenza virus infection was associated with influenza symptoms and shedding durations. Further studies are needed to determine if the nose/throat microbiota is a viable target for reducing influenza symptoms and transmission.


Subject(s)
Influenza, Human/transmission , Microbiota/physiology , Nose/microbiology , Pharynx/microbiology , Virus Shedding/physiology , Adolescent , Adult , Antiviral Agents/therapeutic use , Child , Child, Preschool , Family Characteristics , Female , Humans , Infant , Influenza, Human/drug therapy , Male , Nicaragua , Oseltamivir/therapeutic use , Real-Time Polymerase Chain Reaction , Smoking , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL